A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis

NCT00812799 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

374

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinoconjunctivitis

Interventions

DRUG: Oralgen
OTHER: placebo control

Sponsor

Artu Biologicals